Skip to main content
Epocrates Online
Contact us
Explore features
Reach clinicians
Buy now
By
vgreene
, 7 May, 2020
Drugs under investigation include: anakinra, canakinumab
By
vgreene
, 7 May, 2020
Level 0 (Resume all services):
By
vgreene
, 7 May, 2020
Routine service for all pts
By
vgreene
, 7 May, 2020
Level 1 (Resume most services):
By
vgreene
, 7 May, 2020
Majority of cases, but stable cases may be deferred
By
vgreene
, 7 May, 2020
Level 2 (Resume some services):
By
vgreene
, 7 May, 2020
Other: select cases (mesenteric ischemia, symptomatic DVT)
By
vgreene
, 7 May, 2020
TEVAR/EVAR: all in-pts, select out-pts
By
vgreene
, 7 May, 2020
Critical limb ischemia: all in-pts, select out-pts
By
vgreene
, 7 May, 2020
Coordinate level of care w/ public health officials
Pagination
First page
Previous page
…
Page
1796
Page
1797
Page
1798
Page
1799
Current page
1800
Page
1801
Page
1802
Page
1803
Page
1804
…
Next page
Last page
About Us
Company Overview
Media Relations
Contact
Editorial Policy
Editorial Process
Third-Party Sponsorship Policy
athenahealth
Products
Core Products
Mobile CME
Product Licenses
Business Solutions
Pharma
Market Research
Institutions
Support
Support Center
Install
My Account
Stay Connected
Facebook
Twitter
YouTube